"indian-pharma-industry"

India’s pharma success story cannot rest on cheap generics alone. It must be backed by credibility, stronger audits, criminal liability for negligence and swift justice

The projection is in line with the estimates in the Union Budget 2021-22 presented in Parliament earlier this week.